← Leaderboards
Alice McConnell
Speragen, Inc.
$409,871
Attributed
$671,069
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $446.1K · FY2016–18$500K$375K$250K$125K$0
'16
'17
'18
Funding mix
By agency
NIH$671,069 · 3
By mechanism
R41$671,069 · 3
Top collaborators
- K Michael Gibson2 shared
- Jean-Baptiste O Roullet1 shared
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyPreclinical StudySuccinate-Semialdehyde Dehydrogenase DeficiencyClinical ResearchAffinityBiochemicalMetabolismReceptorDevelopmental Delay DisordersBaseFunctional DisorderAldehyde DehydrogenasesFamilyFoundationsEpilepsyEvaluationFutureDoseClinical TrialsCommercializationCommunitiesDown-RegulationBrainAggressive Behavior
Grant awards (3)
Farnesol as Novel Treatment in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$223,095
R41 · FY2018 · NS · contact PI
In Silico Identification of Novel GHB Receptor Ligands for SSADH Deficiency, a Disorder of GABA Metabolism$223,038
R41 · FY2018 · NS · contact PI
Preclinical Evaluation of NCS-382 in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$224,936
R41 · FY2016 · NS · contact PI